Acupuncture for prevention and treatment of cancer-related fatigue during chemotherapy: a study protocol for a multicenter, randomized, controlled clinical trial

Beijing Municipal Administration of Hospitals0 sites112 target enrollmentMarch 24, 2015

Overview

No summary available.

Registry

who.int

Start Date

March 24, 2015

End Date

TBD

Last Updated

10 years ago

Study Type

Interventional

Sex

All

Sponsor

Beijing Municipal Administration of Hospitals

•1\. Patients with a definite pathologic diagnosis of breast cancer or lung cancer who had completed chemotherapy and/or radiotherapy at least 3 months, or never received chemotherapy and/or radiotherapy ever before
•2\. Aged 18\-75
•3\. There are at least two cycles of chemotherapy planned during the study program
•4\. Eastern Cooperative Oncology Group (ECOG) performance status 0\-2
•5\. Traditional Chinese Medicine (TCM) syndrome is differentiated as deficiency of spleen qi and stomach qi
•6\. Anticipated survival time is more than 6 months
•7\. All patients provided written informed consent before enrollment

•1\. Complicated with other serious heart, liver, kidney, immune and hematopoietic system diseases
•2\. Pregnant women or women who are breastfeeding
•3\. Patients who were on active treatment for anaemia (i.e., EPO or blood transfusions)
•4\. Patients who were receiving steroids to alleviate fatigue
•5\. Patients who had been diagnosed with depression, anxiety disorders, mental illness and cognitive disorders
•6\. Patients who had low platelet count or suffered from a bleeding disorder (e.g., haemophilia)
•7\. Complicated with sepsis or bacteremia
•8\. Patients who had lymphoedema at the area of the acupuncture points
•9\. Patients who are allergic to stainless steel needle or had needle phobia